<DOC>
	<DOCNO>NCT00561821</DOCNO>
	<brief_summary>This study conduct investigate efficacy treatment Org 50081 ( Esmirtazapine ) compare placebo elderly participant chronic primary insomnia . Primary efficacy variable Wake time After Sleep Onset ( WASO ) , average in-treatment time point measure polysomnography ( PSG ) .</brief_summary>
	<brief_title>Efficacy Safety Study Org 50081 ( Esmirtazapine ) Elderly Participants ( P05709 )</brief_title>
	<detailed_description>Insomnia common complaint disorder throughout world . About one third population industrial country report difficulty initiate maintain sleep , result non-refreshing non-restorative sleep . The majority insomniac suffer chronically complaint . The maleic acid salt Org 4420 , code name Org 50081 , know Esmirtazapine , select development treatment insomnia . The first clinical trial Esmirtazapine proof-of-concept trial four-way cross-over design . All 3 Esmirtazapine dose group show statistically significant positive effect TST ( objective subjective ) WASO , compare placebo . The current study design assess efficacy safety Esmirtazapine double-blind , placebo-controlled , parallel , randomized trial elderly participant suffer chronic primary insomnia .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Sleep Initiation Maintenance Disorders</mesh_term>
	<mesh_term>Mental Disorders</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Sleep Wake Disorders</mesh_term>
	<mesh_term>Parasomnias</mesh_term>
	<mesh_term>Dyssomnias</mesh_term>
	<mesh_term>Mirtazapine</mesh_term>
	<criteria>least 65 year age screening ; sign write informed consent scope nature investigation explain , screen evaluation ; able speak , read understand language investigator , study staff ( include raters ) inform consent form , possess ability respond question , follow instruction complete questionnaire ; demonstrate capability independently complete LogPad questionnaire complete questionnaire least 6 7 day week precede randomization ; regular sleep pattern , mean bedtime regularly occur 2100 hour 2400 hour , variation boundary 2 times/ week , 58.5 hour bed ; document diagnosis chronic primary insomnia , define fulfillment Diagnostic Statistical Manual Mental Disorders IV Text Revision ( DSMIVTR ) criteria primary insomnia ( DSMIVTR 307.42 ) duration &gt; = 1 month ; fulfill follow PSG criterion two screening/baseline PSG night : average Total Sleep Time ( TST ) &lt; 6.5 h ( night great equal 3 h &lt; 7 h ) , average WASO great equal 45 minute ( night great equal 30 min ) , average Latency Persistent Sleep ( LPS ) 15 min ( night great equal 10 min ) . sleep disorder ( DSMIVTR ) , sleep related breathing disorder ApneaHypopnea Index ( AHI ) great equal 15 ) , Periodic Leg Movements Arousals Index ( PLMAI ) great equal 10 ) , restless leg syndrome , narcolepsy , circadian sleep wake rhythm disorder , Rapid Eye Movement ( REM ) behavioral disorder parasomnia ; significant medical DSMIVTR psychiatric illness cause sleep disturbance ; currently meet diagnostic criterion DSMIVTR depression Major Depressive Disorder ( MDD ) diagnose treat MDD within last 2 year ; history bipolar disorder , history suicide attempt family history suicide . A family history suicide define history suicide first second degree family ( parent , sibling , grandparent , offspring ) , pattern complete suicide ( one ) third degree family ( aunt , uncle , niece nephew ) ; history sign dementia serious cognitive impairment , define score less 26 MiniMental State Examination ; significant , unstable medical illness e.g . acute chronic pain , hepatic , renal , metabolic cardiac disease ; serious head injury stroke within past year , history ( nonfebrile ) seizures ; clinically relevant electrocardiogram ( ECG ) abnormalities screen , judged investigator ; clinically relevant abnormal hematology biochemistry value screen , judged investigator ; DSMIVTR substance abuse DSMIVTR addiction within last year ; drink 2 alcoholic drink day . One drink approximately equal : 12 oz 360 ml beer ( regular light ) , 4 oz 120 ml red white wine , 2 oz 60 ml desert wine ( e.g . port , sherry ) , 12 oz 360 ml wine cooler ( regular light ) , 1 oz 30 ml spirit ( 80 100 proof , e.g . whiskey , vodka ) ; routinely sleep daytime ( nap ) 20 minute per day , 3 day per week ; night worker rotate shift worker currently , past 6 month use psychotropic drug affect sleep within two week prior randomization ( fluoxetine : five week ) ; use concomitant medication affect sleep ( e.g . anxiolytic , sedative , antidepressant , antipsychotic , centrally active sedate antihistamine , central nervous system ( CNS ) stimulant , alpha2antagonists , respiratory stimulant decongestant ) ; smoke &gt; 15 cigarette per day and/or abstain smoking night ; drink excessive amount caffeinated beverages/day ( 500 mg caffeine per day ) ; body mass index ( BMI ) &gt; = 36 ; positive urine drug screen screen baseline ; know hypersensitivity mirtazapine excipients ;</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>elderly</keyword>
	<keyword>randomize</keyword>
	<keyword>placebo control</keyword>
</DOC>